Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

19.2%

5 terminated out of 26 trials

Success Rate

78.3%

-8.2% vs benchmark

Late-Stage Pipeline

23%

6 trials in Phase 3/4

Results Transparency

33%

6 of 18 completed with results

Key Signals

6 with results78% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (3)
P 1 (7)
P 2 (8)
P 3 (5)
P 4 (1)

Trial Status

Completed18
Terminated5
Recruiting1
Active Not Recruiting1
Unknown1

Trial Success Rate

78.3%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07120945Not ApplicableRecruiting

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

NCT00544115Phase 2Active Not Recruiting

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

NCT00006083Phase 3Completed

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

NCT00070382Phase 3Completed

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

NCT00064194Phase 3CompletedPrimary

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

NCT00003687Phase 3Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00021294Phase 2Completed

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

NCT00854581Phase 4Terminated

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

NCT00524485Not ApplicableTerminatedPrimary

Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis

NCT00589602Phase 2Terminated

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

NCT00453336Phase 2Completed

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

NCT00118066Phase 2TerminatedPrimary

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

NCT00898066Completed

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

NCT00004258Phase 1Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00003406Phase 1Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

NCT00030901Phase 3CompletedPrimary

S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate

NCT00004904Phase 1Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232Phase 1Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00006379Phase 2Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00002504Phase 2Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

Scroll to load more

Research Network

Activity Timeline